Jul 22, 2026 10:12 PM
Updated Jul 30, 2026 5:52 PM
Madeline Eiken and Charlie Childs cofounded Intero Biosystems in 2024. The company grows miniature human intestines in the lab in order to test medications to predict how they will work in patients. They hope this will become an alternative to animal testing. Intero Biosystems has raised $2.6 million in investment backing.
Comments
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy